Biosimilars hold great cost savings promises for payers and patients alike—but only if prescribers and patients are willing to make the switch.
Good leaders don’t just rely on one managerial style—they get the best out of every team member by meeting their needs.
Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.
Better care at lower costs is the ultimate goal across healthcare today. Here’s how pharmacists can help.
Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.
How can payers cope with new, ultra-expensive therapies?
The new CGRP therapies provide a novel, migraine-specific mechanism with effective results. Read more.
No longer a technology for science fiction, artificial intelligence and machine learning offer the multifaceted approach that healthcare is waiting for.
There are many ways to measure success and value—but the future of value-based care will rely on patient-reported outcomes.
To get a pulse on the U.S.